PT Trimegah Bangun Persada Tbk
IDX:NCKL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PT Trimegah Bangun Persada Tbk
IDX:NCKL
|
ID |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Conmed Corp
NYSE:CNMD
|
US |
|
Lifetime Brands Inc
NASDAQ:LCUT
|
US |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
B
|
Baltic Classifieds Group PLC
LSE:BCG
|
UK |
|
A
|
Arabian Drilling Co
SAU:2381
|
SA |
|
SRF Ltd
NSE:SRF
|
IN |
Intrinsic Value
The intrinsic value for PT Trimegah Bangun Persada Tbk (NCKL) under the Base Case is hidden IDR. Compared with the current market price of 865 IDR, the stock appears hidden .
NCKL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if NCKL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for PT Trimegah Bangun Persada Tbk.
The intrinsic value for PT Trimegah Bangun Persada Tbk (NCKL) under the Base Case is hidden IDR.
Compared with the current market price of 865 IDR, the stock appears hidden.